Eagle Asset Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
– Sell
-922,101
Closed -$49.3M – 681
2016
Q1
$49.3M Sell
922,101
-48,610
-5% -$3.59M 0.34% 93
2015
Q4
$110M Sell
970,711
-201,769
-17% -$22.2M 0.73% 17
2015
Q3
$138M Sell
1,172,480
-353,978
-23% -$46.2M 0.94% 7
2015
Q2
$118M Sell
1,526,458
-49,492
-3% -$3.24M 0.66% 27
2015
Q1
$91.2M Sell
1,575,950
-752,227
-32% -$31.9M 0.52% 48
2014
Q4
$75.1M Buy
2,328,177
+354,829
+18% +$10.7M 0.43% 70
2014
Q3
$48.3M Buy
1,973,348
+568,731
+40% +$11.6M 0.28% 124
2014
Q2
$24.9M Buy
1,404,617
+175,665
+14% +$2.83M 0.14% 205
2014
Q1
$24.6M Buy
+1,228,952
New +$23.8M 0.14% 215

Other funds holding ANAC

Eagle Asset Management's ANAC Position: Q2 2016 in Review

Eagle Asset Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 922,101 shares — an estimated $49.3M sold.

Eagle Asset Management first reported a position in ANAC in Q1 2014 and held it in 9 quarters. The position peaked at $138M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Eagle Asset Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Eagle Asset Management sold 922,101 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $49.3M.
  • Eagle Asset Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2014 and held it in 9 quarters.
  • Eagle Asset Management's ANACOR PHARMACEUTICALS INC COM position peaked at $138M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Eagle Asset Management's 13F filing for Q2 2016, filed 19 Jul 2016.